Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00214981 · ClinicalTrials.gov registry record · Phase 3
Evaluate the Safety and Efficacy of Modafinil in Children and Adolescents With ADHD
A Phase 3 study, sponsored by Cephalon.
- Completed
- Registry status
- Phase 3
- Development phase
NCT00214981: Completed Phase 3 study, sponsored by Cephalon.
NCT00214981 is a Phase 3 study that has completed, run by Cephalon. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00214981, a Phase 3 study, has completed, sponsored by Cephalon.
- COMPLETED
- Registry status
- Phase 3
- Development phase
Study Summary
Primary objective of this study is to evaluate the safety of treatment with modafinil film-coated tablet.
Interventions
- DRUG Modafinil
Trial Details
| Field | Value |
|---|---|
| Start Date | 2003-09 |
| Est. Completion | 2006-09 |
| Phase | Phase 3 |
What the finished NCT00214981 record still lists
NCT00214981 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Modafinil is the first listed.
NCT00214981 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00214981 about?
NCT00214981 is a clinical study titled "Evaluate the Safety and Efficacy of Modafinil in Children and Adolescents With ADHD". Primary objective of this study is to evaluate the safety of treatment with modafinil film-coated tablet.
What is the current status of trial NCT00214981?
This trial is currently completed. It is a Phase 3 study. The study started on 2003-09. Estimated completion is 2006-09.
What interventions are being tested in trial NCT00214981?
The interventions under investigation include: Modafinil (DRUG).
Who is sponsoring clinical trial NCT00214981?
This trial is sponsored by Cephalon, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia